Simultaneous Detection and Evaluation of Four Subsets of CD4+ T Lymphocyte in Lesions and Peripheral Blood in Endometriosis

American Journal of Reproductive Immunology

Volumn 74, Issue 6, 2015, Pages 480-486

  Takamura, Masashi ^a   Koga, Kaori ^a   Izumi, Gentaro ^a   Hirata, Tetsuya ^a   Harada, Miyuki ^a   Hirota, Yasushi ^a   Hiraike, Osamu ^a   Fujii, Tomoyuki ^a   Osuga, Yutaka ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Endometrium; Proportion; Regulatory T cells; Th1; Th17; Th2

Indexed keywords

CD4 ANTIGEN; CYTOKINE;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; EVALUATION STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOPHYSIOLOGY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; CELL SEPARATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; CYTOKINES; ENDOMETRIOSIS; FEMALE; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; T-LYMPHOCYTE SUBSETS;

EID: 84983130702     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12426     Document Type: Article

References (48)

1. Momoeda M, Taketani Y, Terakawa N, Hoshiai H, Tanaka K, Tsutsumi O, Osuga Y, Maruyama M, Harada T, Obata K, Hayashi K: Is endometriosis really associated with pain? Gynecol Obstet Invest 2002; 54 (Suppl. 1):18-21; discussion 21-13.
2. Osuga Y, Koga K, Tsutsumi O, Yano T, Maruyama M, Kugu K, Momoeda M, Taketani Y: Role of laparoscopy in the treatment of endometriosis-associated infertility. Gynecol Obstet Invest 2002; 53(Suppl. 1):33-39.
3. Reis FM, Petraglia F, Taylor RN: Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis. Hum Reprod Update 2013; 19:406-418.
4. Bianco B, Andre GM, Vilarino FL, Peluso C, Mafra FA, Christofolini DM, Barbosa CP: The possible role of genetic variants in autoimmune-related genes in the development of endometriosis. Hum Immunol 2012; 73:306-315.
5. Bellelis P, Podgaec S, Abrao MS: Environmental factors and endometriosis. Rev Assoc Med Bras 2011; 57:448-452.
6. Lebovic DI, Mueller MD, Taylor RN: Immunobiology of endometriosis. Fertil Steril 2001; 75:1-10.
7. Capobianco A, Rovere-Querini P: Endometriosis, a disease of the macrophage. Front Immunol 2013; 4:9.
8. Schulke L, Berbic M, Manconi F, Tokushige N, Markham R, Fraser IS: Dendritic cell populations in the eutopic and ectopic endometrium of women with endometriosis. Hum Reprod 2009; 24:1695-1703.
9. Sikora J, Mielczarek-Palacz A, Kondera-Anasz Z: Role of natural killer cell activity in the pathogenesis of endometriosis. Curr Med Chem 2011; 18:200-208.
10. Osuga Y, Koga K, Hirota Y, Hirata T, Yoshino O, Taketani Y: Lymphocytes in endometriosis. Am J Reprod Immunol 2011; 65:1-10.
11. Gogacz M, Winkler I, Bojarska-Junak A, Tabarkiewicz J, Semczuk A, Rechberger T, Adamiak A: T regulatory lymphocytes in patients with endometriosis. Mol Med Rep 2014; 10:1072-1076.
12. Kyama CM, Mihalyi A, Simsa P, Falconer H, Fulop V, Mwenda JM, Peeraer K, Tomassetti C, Meuleman C, D'Hooghe TM: Role of cytokines in the endometrial-peritoneal cross-talk and development of endometriosis. Front Biosci 2009; 1:444-454.
13. Agic A, Xu H, Finas D, Banz C, Diedrich K, Hornung D: Is endometriosis associated with systemic subclinical inflammation? Gynecol Obstet Invest 2006; 62:139-147.
14. Del Prete G: The concept of type-1 and type-2 helper T cells and their cytokines in humans. Int Rev Immunol 1998; 16:427-455.
15. Singh VK, Mehrotra S, Agarwal SS: The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy. Immunol Res 1999; 20:147-161.
16. OuYang Z, Hirota Y, Osuga Y, Hamasaki K, Hasegawa A, Tajima T, Hirata T, Koga K, Yoshino O, Harada M, Takemura Y, Nose E, Yano T, Taketani Y: Interleukin-4 stimulates proliferation of endometriotic stromal cells. Am J Pathol 2008; 173:463-469.
17. Chen P, Zhang Z, Chen Q, Ren F, Li T, Zhang C, Wang D: Expression of Th1 and Th2 cytokine-associated transcription factors, T-bet and GATA-3, in the eutopic endometrium of women with endometriosis. Acta Histochem 2012; 114:779-784.
18. Antsiferova YS, Sotnikova NY, Posiseeva LV, Shor AL: Changes in the T-helper cytokine profile and in lymphocyte activation at the systemic and local levels in women with endometriosis. Fertil Steril 2005; 84:1705-1711.
19. Azizi G, Jadidi-Niaragh F, Mirshafiey A: Th17 cells in immunopathogenesis and treatment of rheumatoid arthritis. Int J Rheumat Dis 2013; 16:243-253.
20. Niu Q, Cai B, Huang ZC, Shi YY, Wang LL: Disturbed Th17/Treg balance in patients with rheumatoid arthritis. Rheumatol Int 2012; 32:2731-2736.
21. Lina C, Conghua W, Nan L, Ping Z: Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis. J Clin Immunol 2011; 31:596-605.
22. Troncone E, Marafini I, Pallone F, Monteleone G: Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad. Int Rev Immunol 2013; 32:526-533.
23. Brand S: Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009; 58:1152-1167.
24. Chao K, Zhang S, Yao J, He Y, Chen B, Zeng Z, Zhong B, Chen M: Imbalances of CD4(+) T-cell subgroups in Crohn's disease and their relationship with disease activity and prognosis. J Gastroenterol Hepatol 2014; 29:1808-1814.
25. Nalbandian A, Crispin JC, Tsokos GC: Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol 2009; 157:209-215.
26. Martin JC, Baeten DL, Josien R: Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus. Clin Immunol 2014; 154:1-12.
27. Talaat RM, Mohamed SF, Bassyouni IH, Raouf AA: Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity. Cytokine 2015; 72:146-153.
28. Elloso MM, Gomez-Angelats M, Fourie AM: Targeting the Th17 pathway in psoriasis. J Leukoc Biol 2012; 92:1187-1197.
29. Furuhashi T, Saito C, Torii K, Nishida E, Yamazaki S, Morita A: Photo(chemo)therapy reduces circulating Th17 cells and restores circulating regulatory T cells in psoriasis. PLoS One 2013; 8:e54895.
30. Hirata T, Osuga Y, Hamasaki K, Yoshino O, Ito M, Hasegawa A, Takemura Y, Hirota Y, Nose E, Morimoto C, Harada M, Koga K, Tajima T, Saito S, Yano T, Taketani Y: Interleukin (IL)-17A stimulates IL-8 secretion, cyclooxygensase-2 expression, and cell proliferation of endometriotic stromal cells. Endocrinology 2008; 149:1260-1267.
31. Basta P, Koper K, Kazmierczak W, Wisniewski M, Makarewicz A, Dutsch-Wicherek M, Kojs Z, Popiela TJ, Slusarz R, Dubiel M, Wicherek L: The biological role of Treg cells in ectopic endometrium homeostasis. Histol Histopathol 2014; 29:1217-1233.
32. Mjosberg J, Berg G, Jenmalm MC, Ernerudh J: FOXP3+ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua. Biol Reprod 2010; 82:698-705.
33. Li YY, Li CR, Wang GB, Yang J, Zu Y: Investigation of the change in CD4(+) T cell subset in children with Henoch-Schonlein purpura. Rheumatol Int 2012; 32:3785-3792.
34. Urata Y, Osuga Y, Izumi G, Takamura M, Koga K, Nagai M, Harada M, Hirata T, Hirota Y, Yoshino O, Taketani Y: Interleukin-1beta stimulates the secretion of thymic stromal lymphopoietin (TSLP) from endometrioma stromal cells: possible involvement of TSLP in endometriosis. Hum Reprod 2012; 27:3028-3035.
35. Hirata T, Osuga Y, Takamura M, Kodama A, Hirota Y, Koga K, Yoshino O, Harada M, Takemura Y, Yano T, Taketani Y: Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1 beta-, TNF-alpha-, and IL-17A-stimulated endometriotic stromal cells. Endocrinology 2010; 151:5468-5476.
36. Zenewicz LA, Antov A, Flavell RA: CD4 T-cell differentiation and inflammatory bowel disease. Trends Mol Med 2009; 15:199-207.
37. Zhang L, Yang XQ, Cheng J, Hui RS, Gao TW: Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity. Clin Immunol 2010; 135:108-117.
38. Church LD, Filer AD, Hidalgo E, Howlett KA, Thomas AM, Rapecki S, Scheel-Toellner D, Buckley CD, Raza K: Rheumatoid synovial fluid interleukin-17-producing CD4 T cells have abundant tumor necrosis factor-alpha co-expression, but little interleukin-22 and interleukin-23R expression. Arthritis Res Ther 2010; 12:R184.
39. Bergqvist A, Bruse C, Carlberg M, Carlstrom K: Interleukin 1beta, interleukin-6, and tumor necrosis factor-alpha in endometriotic tissue and in endometrium. Fertil Steril 2001; 75:489-495.
40. Basta P, Majka M, Jozwicki W, Lukaszewska E, Knafel A, Grabiec M, Stasienko E, Wicherek L: The frequency of CD25+CD4+ and FOXP3+ regulatory T cells in ectopic endometrium and ectopic decidua. Reprod Biol Endocrinol 2010; 8:116.
41. Szyllo K, Tchorzewski H, Banasik M, Glowacka E, Lewkowicz P, Kamer-Bartosinska A: The involvement of T lymphocytes in the pathogenesis of endometriotic tissues overgrowth in women with endometriosis. Mediators Inflamm 2003; 12:131-138.
42. Olkowska-Truchanowicz J, Bocian K, Maksym RB, Bialoszewska A, Wlodarczyk D, Baranowski W, Zabek J, Korczak-Kowalska G, Malejczyk J: CD4(+) CD25(+) FOXP3(+) regulatory T cells in peripheral blood and peritoneal fluid of patients with endometriosis. Hum Reprod 2013; 28:119-124.
43. Kawashima M, Miossec P: Effect of treatment of rheumatoid arthritis with infliximab on IFN gamma, IL4, T-bet, and GATA-3 expression: link with improvement of systemic inflammation and disease activity. Ann Rheum Dis 2005; 64:415-418.
44. Arroyo-Villa I, Bautista-Caro MB, Balsa A, Aguado-Acin P, Nuno L, Bonilla-Hernan MG, Puig-Kroger A, Martin-Mola E, Miranda-Carus ME: Frequency of Th17 CD4+ T cells in early rheumatoid arthritis: a marker of anti-CCP seropositivity. PLoS One 2012; 7:e42189.
45. Ho HN, Wu MY, Chao KH, Chen CD, Chen SU, Yang YS: Peritoneal interleukin-10 increases with decrease in activated CD4+ T lymphocytes in women with endometriosis. Hum Reprod 1997; 12:2528-2533.
46. Thaci D, Humeniuk J, Frambach Y, Bissonnette R, Goodman JJ, Shevade S, Gong Y, Papavassilis C, Group SS: Secukinumab in psoriasis: randomized, controlled phase 3 trial results assessing the potential to improve treatment response in partial responders (STATURE). Brit J Dermatol 2015; doi: 10.1111/bjd.13814. [Epub ahead of print].
47. Genovese MC, Greenwald M, Cho CS, Berman A, Jin L, Cameron GS, Benichou O, Xie L, Braun D, Berclaz PY, Banerjee S: A phase II randomized study of subcutaneous ixekizumab, an anti-interleukin-17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an inadequate response to tumor necrosis factor inhibitors. Arthrit Rheumatol 2014; 66:1693-1704.
48. Globig AM, Hennecke N, Martin B, Seidl M, Ruf G, Hasselblatt P, Thimme R, Bengsch B: Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-gamma+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease. Inflamm Bowel Dis 2014; 20:2321-2329.